Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bissonnette

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|August 2, 2021
Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center StageHeena Mehta, Julianty Angsana, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2015
Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitisShunya Mashiko, Salim Bouguermouh, Manuel Rubio, et al.
Journal of the American Academy of Dermatology|October 7, 2024
Hand Eczema. Part 2: Prevention, management, and treatmentRobert Bissonnette, Tove Agner, James S Taylor, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2025
Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand EczemaDiamant Thaçi, Melinda Gooderham, Paola Lovato, et al.
Journal of the American Academy of Dermatology|May 25, 2010
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanerceptRobert Bissonnette, Chantal Bolduc, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|January 20, 2007
XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Efficacy outcomes in patients using alefacept in the AWARE studyIan Landells, Gordon Searles, Robert Bissonnette, et al.
Alternative Medicine Review : a Journal of Clinical Therapeutic|December 12, 2007
XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 28, 2003
Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis inductionJean-François Tremblay, Sylvie Dussault, Gilles Viau, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 28, 2025
Reply to 'Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema'Diamant Thaçi, Melinda Gooderham, Paola Lovato, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|August 2, 2021
Inflammatory Skin Disorders: Monocyte-Derived Cells Take Center StageHeena Mehta, Julianty Angsana, Robert Bissonnette, et al.
The Journal of Allergy and Clinical Immunology|March 21, 2015
Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitisShunya Mashiko, Salim Bouguermouh, Manuel Rubio, et al.
Journal of the American Academy of Dermatology|October 7, 2024
Hand Eczema. Part 2: Prevention, management, and treatmentRobert Bissonnette, Tove Agner, James S Taylor, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 17, 2025
Systemic exposure and bioavailability of delgocitinib cream in adults with moderate to severe Chronic Hand EczemaDiamant Thaçi, Melinda Gooderham, Paola Lovato, et al.
Journal of the American Academy of Dermatology|May 25, 2010
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanerceptRobert Bissonnette, Chantal Bolduc, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|January 20, 2007
XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Efficacy outcomes in patients using alefacept in the AWARE studyIan Landells, Gordon Searles, Robert Bissonnette, et al.
Alternative Medicine Review : a Journal of Clinical Therapeutic|December 12, 2007
XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 28, 2003
Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis inductionJean-François Tremblay, Sylvie Dussault, Gilles Viau, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 28, 2025
Reply to 'Delayed absorption and systemic variability of topical delgocitinib in Chronic Hand Eczema'Diamant Thaçi, Melinda Gooderham, Paola Lovato, et al.
Pageof 23